Annual CAPEX
$22.21 M
-$6.57 M-22.83%
31 December 2023
Summary:
Fulgent Genetics annual capital expenditures is currently $22.21 million, with the most recent change of -$6.57 million (-22.83%) on 31 December 2023. During the last 3 years, it has fallen by -$12.92 million (-36.79%). FLGT annual CAPEX is now -36.79% below its all-time high of $35.13 million, reached on 31 December 2020.FLGT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$19.54 M
+$6.59 M+50.93%
30 September 2024
Summary:
Fulgent Genetics quarterly capital expenditures is currently $19.54 million, with the most recent change of +$6.59 million (+50.93%) on 30 September 2024. Over the past year, it has increased by +$14.61 million (+296.85%). FLGT quarterly CAPEX is now -17.89% below its all-time high of $23.79 million, reached on 31 December 2020.FLGT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$39.64 M
+$14.61 M+58.39%
30 September 2024
Summary:
Fulgent Genetics TTM capital expenditures is currently $39.64 million, with the most recent change of +$14.61 million (+58.39%) on 30 September 2024. Over the past year, it has increased by +$5.82 million (+17.21%). FLGT TTM CAPEX is now -18.01% below its all-time high of $48.35 million, reached on 30 June 2021.FLGT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.8% | +296.9% | +17.2% |
| 3 y3 years | -36.8% | +474.3% | -4.8% |
| 5 y5 years | +684.1% | +10000.0% | +4597.0% |
FLGT CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -36.8% | at low | at high | +860.5% | -4.8% | +123.8% |
| 5 y | 5 years | -36.8% | +1778.8% | -17.9% | >+9999.0% | -18.0% | +4597.0% |
| alltime | all time | -36.8% | +2937.9% | -17.9% | >+9999.0% | -18.0% | >+9999.0% |
Fulgent Genetics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.54 M(+50.9%) | $39.64 M(+58.4%) |
| June 2024 | - | $12.94 M(+219.1%) | $25.03 M(+3.3%) |
| Mar 2024 | - | $4.06 M(+30.6%) | $24.23 M(+9.1%) |
| Dec 2023 | $22.21 M(-22.8%) | $3.11 M(-36.9%) | $22.21 M(-34.3%) |
| Sept 2023 | - | $4.92 M(-59.5%) | $33.82 M(-1.5%) |
| June 2023 | - | $12.14 M(+497.1%) | $34.34 M(+34.9%) |
| Mar 2023 | - | $2.03 M(-86.2%) | $25.45 M(-11.6%) |
| Dec 2022 | $28.77 M(+20.7%) | $14.72 M(+170.9%) | $28.77 M(+43.4%) |
| Sept 2022 | - | $5.43 M(+66.8%) | $20.07 M(+11.3%) |
| June 2022 | - | $3.26 M(-39.2%) | $18.04 M(+1.8%) |
| Mar 2022 | - | $5.36 M(-10.9%) | $17.71 M(-25.7%) |
| Dec 2021 | $23.84 M(-32.1%) | $6.01 M(+76.8%) | $23.84 M(-42.7%) |
| Sept 2021 | - | $3.40 M(+15.9%) | $41.62 M(-13.9%) |
| June 2021 | - | $2.94 M(-74.5%) | $48.35 M(+5.5%) |
| Mar 2021 | - | $11.49 M(-51.7%) | $45.83 M(+30.4%) |
| Dec 2020 | $35.13 M | $23.79 M(+134.9%) | $35.13 M(+197.8%) |
| Sept 2020 | - | $10.13 M(+2364.5%) | $11.80 M(+571.8%) |
| June 2020 | - | $411.00 K(-48.4%) | $1.76 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $796.00 K(+72.7%) | $1.84 M(+56.0%) |
| Dec 2019 | $1.18 M(-58.3%) | $461.00 K(+423.9%) | $1.18 M(+40.0%) |
| Sept 2019 | - | $88.00 K(-82.4%) | $844.00 K(-53.2%) |
| June 2019 | - | $499.00 K(+272.4%) | $1.80 M(-2.5%) |
| Mar 2019 | - | $134.00 K(+8.9%) | $1.85 M(-34.7%) |
| Dec 2018 | $2.83 M(-47.1%) | $123.00 K(-88.3%) | $2.83 M(-26.4%) |
| Sept 2018 | - | $1.05 M(+91.8%) | $3.85 M(-30.0%) |
| June 2018 | - | $546.00 K(-51.1%) | $5.50 M(-13.8%) |
| Mar 2018 | - | $1.12 M(-2.2%) | $6.38 M(+19.2%) |
| Dec 2017 | $5.36 M(+41.4%) | $1.14 M(-57.7%) | $5.36 M(+15.8%) |
| Sept 2017 | - | $2.70 M(+89.1%) | $4.62 M(-2.5%) |
| June 2017 | - | $1.43 M(+1485.6%) | $4.74 M(+28.1%) |
| Mar 2017 | - | $90.00 K(-78.0%) | $3.70 M(-2.3%) |
| Dec 2016 | $3.79 M(+80.4%) | $409.00 K(-85.5%) | $3.79 M(+12.1%) |
| Sept 2016 | - | $2.82 M(+629.5%) | $3.38 M(+500.2%) |
| June 2016 | - | $386.00 K(+118.1%) | $563.00 K(+218.1%) |
| Mar 2016 | - | $177.00 K | $177.00 K |
| Dec 2015 | $2.10 M(+187.3%) | - | - |
| Dec 2014 | $731.00 K | - | - |
FAQ
- What is Fulgent Genetics annual capital expenditures?
- What is the all time high annual CAPEX for Fulgent Genetics?
- What is Fulgent Genetics annual CAPEX year-on-year change?
- What is Fulgent Genetics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Fulgent Genetics?
- What is Fulgent Genetics quarterly CAPEX year-on-year change?
- What is Fulgent Genetics TTM capital expenditures?
- What is the all time high TTM CAPEX for Fulgent Genetics?
- What is Fulgent Genetics TTM CAPEX year-on-year change?
What is Fulgent Genetics annual capital expenditures?
The current annual CAPEX of FLGT is $22.21 M
What is the all time high annual CAPEX for Fulgent Genetics?
Fulgent Genetics all-time high annual capital expenditures is $35.13 M
What is Fulgent Genetics annual CAPEX year-on-year change?
Over the past year, FLGT annual capital expenditures has changed by -$6.57 M (-22.83%)
What is Fulgent Genetics quarterly capital expenditures?
The current quarterly CAPEX of FLGT is $19.54 M
What is the all time high quarterly CAPEX for Fulgent Genetics?
Fulgent Genetics all-time high quarterly capital expenditures is $23.79 M
What is Fulgent Genetics quarterly CAPEX year-on-year change?
Over the past year, FLGT quarterly capital expenditures has changed by +$14.61 M (+296.85%)
What is Fulgent Genetics TTM capital expenditures?
The current TTM CAPEX of FLGT is $39.64 M
What is the all time high TTM CAPEX for Fulgent Genetics?
Fulgent Genetics all-time high TTM capital expenditures is $48.35 M
What is Fulgent Genetics TTM CAPEX year-on-year change?
Over the past year, FLGT TTM capital expenditures has changed by +$5.82 M (+17.21%)